Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CANAGLIFLOZIN Cause Urinary incontinence? 58 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 58 reports of Urinary incontinence have been filed in association with CANAGLIFLOZIN (INVOKANA). This represents 0.2% of all adverse event reports for CANAGLIFLOZIN.

58
Reports of Urinary incontinence with CANAGLIFLOZIN
0.2%
of all CANAGLIFLOZIN reports
1
Deaths
12
Hospitalizations

How Dangerous Is Urinary incontinence From CANAGLIFLOZIN?

Of the 58 reports, 1 (1.7%) resulted in death, 12 (20.7%) required hospitalization, and 1 (1.7%) were considered life-threatening.

Is Urinary incontinence Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CANAGLIFLOZIN. However, 58 reports have been filed with the FAERS database.

What Other Side Effects Does CANAGLIFLOZIN Cause?

Diabetic ketoacidosis (3,413) Toe amputation (2,193) Osteomyelitis (2,146) Acute kidney injury (1,853) Fungal infection (1,385) Gangrene (1,081) Weight decreased (1,014) Cellulitis (1,007) Urinary tract infection (920) Diabetic foot infection (832)

What Other Drugs Cause Urinary incontinence?

MIRABEGRON (611) ADALIMUMAB (471) FINGOLIMOD (470) OCRELIZUMAB (431) RISPERIDONE (406) TERIFLUNOMIDE (365) DIMETHYL (355) ARIPIPRAZOLE (350) DALFAMPRIDINE (344) QUETIAPINE (336)

Which CANAGLIFLOZIN Alternatives Have Lower Urinary incontinence Risk?

CANAGLIFLOZIN vs CANAGLIFLOZIN\METFORMIN CANAGLIFLOZIN vs CANAKINUMAB CANAGLIFLOZIN vs CANDESARTAN CANAGLIFLOZIN vs CANDESARTAN CILEXETIL CANAGLIFLOZIN vs CANDESARTAN CILEXETIL\HYDROCHLOROTHIAZIDE

Related Pages

CANAGLIFLOZIN Full Profile All Urinary incontinence Reports All Drugs Causing Urinary incontinence CANAGLIFLOZIN Demographics